NCT06303921View on ClinicalTrials.gov

Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 16, 2024

Primary Completion Date

February 28, 2029

Study Completion Date

February 28, 2029

Conditions
Tauopathies
Interventions
DRUG

11C-M503 PET

2 hour Positron Emission Tomography (PET) scan using new radiotracer 11C-M503

DIAGNOSTIC_TEST

Brain MRI

MRI scan of brain.

DIAGNOSTIC_TEST

Amyloid PET

PET scan with Florbetaben F18 or 11C-PiB

BEHAVIORAL

Neurological assessments

Neurological assessments, including a video interview.

Trial Locations (3)

19104

RECRUITING

University of Pennsylvania, Philadelphia

63110

RECRUITING

Washington University in St. Louis, St Louis

06510

RECRUITING

Yale New Haven Hospital, New Haven

All Listed Sponsors
lead

University of Pennsylvania

OTHER